Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-17-011566
Filing Date
2017-11-14
Accepted
2017-11-14 17:09:49
Documents
70
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q exicure10q93017.htm 10-Q 1446091
2 EXHIBIT 31.1 exicureexhibit311-93017.htm EX-31.1 7971
3 EXHIBIT 31.2 exicureexhibit312-93017.htm EX-31.2 9097
4 EXHIBIT 32.1 exicureexhibit321-93017.htm EX-32.1 9465
  Complete submission text file 0001628280-17-011566.txt   5870629

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT xcur-20170930.xml EX-101.INS 847513
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xcur-20170930.xsd EX-101.SCH 51999
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xcur-20170930_cal.xml EX-101.CAL 63332
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xcur-20170930_def.xml EX-101.DEF 293506
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xcur-20170930_lab.xml EX-101.LAB 632791
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xcur-20170930_pre.xml EX-101.PRE 419857
Mailing Address 8045 LAMON AVE, SUITE 410 SKOKIE IL 60077
Business Address 8045 LAMON AVE, SUITE 410 SKOKIE IL 60077 847-673-1700
EXICURE, INC. (Filer) CIK: 0001698530 (see all company filings)

EIN.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55764 | Film No.: 171202824
SIC: 2834 Pharmaceutical Preparations